Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.
<h4>Background</h4>During the influenza pandemic of 2009/10, the whole-virion, Vero-cell-derived, inactivated, pandemic influenza A (H1N1) vaccine Celvapan® (Baxter) was used in Austria. Celvapan® is adjuvant-free and was the only such vaccine at that time in Europe. The objective of thi...
Guardado en:
Autores principales: | Heimo Lagler, Katharina Grabmeier-Pfistershammer, Veronique Touzeau-Römer, Selma Tobudic, Michael Ramharter, Judith Wenisch, Guido Andrés Gualdoni, Monika Redlberger-Fritz, Theresia Popow-Kraupp, Armin Rieger, Heinz Burgmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/738ef5870b3140ce8bcd14c42c4134ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.
por: Ninon Taylor, et al.
Publicado: (2013) -
Hepatitis E virus seroprevalence in Austrian adults: a nationwide cross-sectional study among civilians and military professionals.
por: Heimo Lagler, et al.
Publicado: (2014) -
Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019
por: Lorenz Schubert, et al.
Publicado: (2021) -
HIV-1 Vpu Blocks Recycling and Biosynthetic Transport of the Intrinsic Immunity Factor CD317/Tetherin To Overcome the Virion Release Restriction
por: Sarah Schmidt, et al.
Publicado: (2011) -
Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions
por: Pablo Carravilla, et al.
Publicado: (2019)